Table 3 Socio-demographic, clinical characteristics and KLRB1 expression in the Validation Cohort.
From: KLRB1 expression in nasopharyngeal mucosa as a prognostic biomarker in COVID-19 patients
Study Variables | Overall Sample (N = 168) |
|---|---|
Age (years) | |
71.1 (SD 15.4) | |
Biological Sex | |
Man | 96 (57.1%) |
Woman | 72 (42.9%) |
Increase in oxygen demand | |
Yes | 89 (52.9%) |
No | 79 (47.1%) |
Smoking habit | |
No | 150 (89.3%) |
Yes | 18 (10.7%) |
Comorbidity | |
No | 98 (58.3%) |
Yes | 70 (41.7%) |
SARS-CoV-2 Vaccination | |
No | 87 (51.8%) |
Yes | 81 (48.2%) |
Outcome | |
Discharged without ICU | 110 (65.5%) |
ICU admittance or exitus | 58 (34.5%) |
KLRB1 expression | |
∆Ct | 9.90 (SD 2.6) |
